Clinical trial
Immunophenotyping of Acute b Cell Lymphoblastic Leukemia
NCT04084327 is registered in ClinicalTrials.gov with South Egypt Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunophenotyping of Acute b Cell Lymphoblastic Leukemia
- Lead sponsor
- South Egypt Cancer Institute
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 1, 2019
- Completion date
- December 1, 2022
- Enrollment
- 50 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acute leukemia